Haojie Shan | Medicine and Dentistry | Best Researcher Award

Posted on 04/11/202404/11/2024 by ScienceFather

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. 📚🏆🦴

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. 🦴🎓🏥

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. 🦴🔬💉✨

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. 🥇🏆🎖️✨

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

Publication Top Notes

A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations 📜
Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations 💉
An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation 💉
Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations ⚖️
Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦵
The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations 🔬
Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Posted on 17/10/202417/10/2024 by ScienceFather

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

Publication Top Notes

Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)

Guanwei Fan | Cardiovascular research | Best Researcher Award

Posted on 14/10/202414/10/2024 by ScienceFather

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

Publication Top Notes

Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖

James Melrose | Health Professions | Best Researcher Award

Posted on 29/08/202429/08/2024 by ScienceFather

Prof. James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose, The University of Sydney, Australia

Based on the provided information, Prof. James Melrose appears to be a highly suitable candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Google Scholar

Academic and Research Excellence

Prof. Melrose has a solid educational background with a B.Sc (Hons) in Biochemistry and a Ph.D. focused on carbohydrate metabolizing enzymes associated with barley. His long-standing affiliation with prestigious institutions such as The University of Sydney and the University of New South Wales highlights his strong academic and research credentials. Over a period of three decades, he has contributed significantly to bone and joint research, particularly in biochemical and immunological studies.

Special Awards and Recognitions

Prof. Melrose has received numerous prestigious awards throughout his career, demonstrating his recognition by the scientific community. Notable awards include the Smith and Nephew Award for his work on the spine, the Matrix Biology Society’s best poster award, and the European Spine Society’s GRAMMER Award. These accolades emphasize his contributions to the field of spine research and matrix biology, marking him as a leading researcher.

Teaching and Mentorship

Prof. Melrose has a strong background in teaching and mentorship, having served as a laboratory demonstrator, lecturer, and co-supervisor of Ph.D. students. His involvement in training and supervising research personnel at the Raymond Purves Bone and Joint Research Laboratories underscores his commitment to education and nurturing the next generation of researchers. This combination of research and teaching excellence enhances his candidacy for the award.

Publication Top Notes

📚 “Are animal models useful for studying human disc disorders/degeneration?”
- European Spine Journal 17, 2-19
- Cited by: 854
- Year: 2008
📘 “Diverse cell signaling events modulated by perlecan”
- Biochemistry 47 (43), 11174-11183
- Cited by: 319
- Year: 2008
🔬 “Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration”
- Spine 27 (12), 1278-1285
- Cited by: 255
- Year: 2002
🧬 “Proteoglycan degradation by the ADAMTS family of proteinases”
- Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12)
- Cited by: 249
- Year: 2011
🔍 “Keratan sulfate, a complex glycosaminoglycan with unique functional capability”
- Glycobiology 28 (4), 182-206
- Cited by: 226
- Year: 2018
🦴 “Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis”
- Arthritis research & therapy 8, 1-6
- Cited by: 200
- Year: 2006
💉 “Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors”
- Journal of Biological Chemistry 277 (17), 14657-14665
- Cited by: 200
- Year: 2002
🔗 “A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of the…”
- The Journal of Anatomy 198 (1), 3-15
- Cited by: 194
- Year: 2001
🧠 “Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms”
- Journal of vascular surgery 24 (1), 82-92
- Cited by: 173
- Year: 1996
📈 “Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study”
- Histochemistry and cell biology 124, 225-235
- Cited by: 164
- Year: 2005

Conclusion

Prof. James Melrose’s extensive research experience, numerous awards, and significant contributions to biochemistry and spine research make him a highly deserving candidate for the Research for Best Researcher Award. His roles in teaching and mentoring further solidify his position as a leader in his field, making a lasting impact on both research and education.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Posted on 23/08/202423/08/2024 by ScienceFather

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

Research focus

The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Dan Yan | Medicine and Dentistry | Best Researcher Award

Posted on 10/06/202410/06/2024 by ScienceFather

Dan Yan | Medicine and Dentistry | Best Researcher Award

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.